BioDiligence mission is to help biotech companies and investors make the best decisions possible while bringing them expertise which is essential to deliver value. Compared to other traditional consulting firms we take the caliber, professionalism and intellectual rigor of Israel’s finest to provide our clients with a turn-key tailored solutions. Our team consists of highly educated analysts, all with Ph.D.’s and proven experience in biotechnology, agricultural biotechnology, and medical cannabis. Our experience and track record in Venture Capital consultation allows us to view the products we analyze from wider perspectives, such as competitive environment, level of innovation and regulation. Our work helps to create an environment for investors allowing them to focus their time and resources on evaluating an appropriately researched deal, instead of assessing technology and capabilities.
Looking for a particular BioDiligence employee's phone or email?
The BioDiligence annual revenue was $1 million in 2026.
Inbar Maymon-Pomeranchik is the Co Founder and Chief Executive Officer of BioDiligence.
1 people are employed at BioDiligence.
The NAICS codes for BioDiligence are [541713, 54171, 5417, 541, 54].
The SIC codes for BioDiligence are [87, 873].